Morishita Jintan Co., Ltd. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Morishita Jintan Co., Ltd. with three other
companies in this sector in Japan:
Linical Company Limited
sales of 8.36 billion Japanese Yen [US$73.61 million]
of which 90%
was Cro Business),
(4.90 billion Japanese Yen [US$43.13 million]
of which 100%
was Therapeutic Medicin), and
Shin Nippon Biomedical Laboratories Ltd
(17.24 billion Japanese Yen [US$151.92 million]
of which 75%
was Pre-Clinical Business).
Morishita Jintan Co., Ltd. reported sales of ¥10.97 billion (US$96.62 million)
March of 2017.
increase of 5.1%
versus 2016, when the company's sales were ¥10.43 billion.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
71.4% in 2017, from
¥14.00 million to ¥24.00 million.
Morishita Jintan Co., Ltd. also saw significant increases in sales in
Healthcare Business (up 17.1% to ¥7.75 billion)
Not all segments of Morishita Jintan Co., Ltd. experienced an increase in sales in 2017:
sales of Capsule Contract Business fell 15.9% to ¥3.19 billion.